Literature DB >> 15002048

Brain lactic alkalosis in Aicardi-Goutières syndrome.

N J Robertson1, P Stafler, R Battini, J Cheong, M Tosetti, M C Bianchi, I J Cox, F M Cowan, G Cioni.   

Abstract

Aicardi-Goutières syndrome is a rare progressive encephalopathy characterized by acquired microcephaly, basal ganglia calcification, and chronic CSF lymphocytosis, raised levels of interferon alpha in CSF and plasma and chill-blain type lesions. A possible mechanism of injury is cytokine related microangiopathy. We report brain imaging and proton (1H) and phosphorus-31 (31P) magnetic resonance spectroscopy (MRS) findings during the first year after birth in two patients. In patient 1 the evolution of brain metabolite ratios and intracellular pH obtained from serial 1H (long TE) and 31P MRS studies are described; in patient 2 a single 1H (short TE) MRS study is described. Imaging findings included basal ganglia calcifications, cerebral atrophy, and leukodystrophy. The MRS results demonstrated that Aicardi-Goutières syndrome is associated with reduced NAA/Cr, reflecting decreased neuronal/axonal density or viability, increased myo-inositol/Cr, reflecting gliosis or osmotic stress and a persisting brain lactic alkalosis. A brain lactic alkalosis has also been observed in those infants surviving perinatal hypoxia-ischaemia but with a poor neurodevelopmental outcome. A possible mechanism leading to brain alkalosis is up-regulation of the Na+/H+ transporter by focal areas of ischaemia related to the microangiopathy or by pro-inflammatory cytokines. Such brain alkalosis may be detrimental to cell survival and may increase glycolytic rate in astrocytes leading to an increased production of lactate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15002048     DOI: 10.1055/s-2004-815787

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  5 in total

1.  Aicardi-Goutières syndrome with emphasis on sonographic features in infancy.

Authors:  L Rossler; C Ludwig-Seibold; Ch Thiels; J Schaper
Journal:  Pediatr Radiol       Date:  2012-05-26

2.  A large homozygous deletion in the SAMHD1 gene causes atypical Aicardi-Goutiéres syndrome associated with mtDNA deletions.

Authors:  Esther Leshinsky-Silver; Gustavo Malinger; Liat Ben-Sira; Dvora Kidron; Sarit Cohen; Shani Inbar; Tali Bezaleli; Arie Levine; Chana Vinkler; Dorit Lev; Tally Lerman-Sagie
Journal:  Eur J Hum Genet       Date:  2010-11-24       Impact factor: 4.246

3.  Peptidylarginine deiminases: novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates.

Authors:  Sigrun Lange; Eridan Rocha-Ferreira; Laura Thei; Priyanka Mawjee; Kate Bennett; Paul R Thompson; Venkataraman Subramanian; Anthony P Nicholas; Donald Peebles; Mariya Hristova; Gennadij Raivich
Journal:  J Neurochem       Date:  2014-05-24       Impact factor: 5.372

Review 4.  Peptidylarginine Deiminases as Drug Targets in Neonatal Hypoxic-Ischemic Encephalopathy.

Authors:  Sigrun Lange
Journal:  Front Neurol       Date:  2016-02-22       Impact factor: 4.003

Review 5.  Mitochondria in skin health, aging, and disease.

Authors:  Annapoorna Sreedhar; Leopoldo Aguilera-Aguirre; Keshav K Singh
Journal:  Cell Death Dis       Date:  2020-06-09       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.